The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

2003/08/14 by A. Richard Green, Annis O. Mechan, J. Martin Elliott +3 · 7 citations
Pharmacology, Toxicology and Pharmaceutics · Psychology · Neuroscience · #Forensic Toxicology and Drug Analysis #Psychedelics and Drug Studies #Neurotransmitter Receptor Influence on Behavior

paper · doi:10.1124/pr.55.3.3

Citations

• Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor

Cited by

• NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment
• Sprague–Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
• A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
• R -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential
• 3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2) ‐deficient rats lacking serotonin in the central nervous system
• Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA
• Patterns of use and harm reduction practices of ecstasy users in Australia